Replies to post #27539 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Agreed illmatix...no offering required or coming now whatsoever!!!

IPCI already had enough cash to get them through September...and now that MNK has officially launched SeroquelXR and PAR already launched 4 more strengths of FocalinXR this year with 2 more strengths remaining to be launched any day now...only a complete and utter fool would be expecting another offering from IPCI since todays news and the recent launch by PAR of 2 additional FocalinXR strengths means IPCI is currently attaining cash flow positive during their fiscal Q3(June/July/August) woot-woot>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Dr. Isa Odidi, CEO and co-founder of Intellipharmaceutics, stated, "We are pleased to share the news of our generic Seroquel XR® launch by our valued partner Mallinckrodt. This is our second ANDA to be commercialized in the U.S. and follows the recent launches of 4 additional strengths of generic Focalin XR® by Par Pharmaceutical, Inc. The launch of generic Seroquel XR® should enhance the significant revenue improvement we have realized thus far in 2017.”

[Tekterra]

2.16 million shares is nothing. They cover them all in half a trading day. You won't catch the shorts unless we get some really amazing news like a Rexista deal signed.